Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · Real-Time Price · USD
3.499
-0.141 (-3.88%)
Nov 21, 2024, 11:26 AM EST - Market open
Vaccinex Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 10 | 8 | 32 | 32 | 46 | 72 | |
Market Cap Growth | 61.00% | -74.16% | 0.35% | -30.87% | -35.71% | 72.33% | |
Enterprise Value | 9 | 8 | 26 | 19 | 62 | 87 | |
Last Close Price | 3.71 | 9.31 | 135.34 | 218.40 | 434.70 | 1018.50 | |
PS Ratio | 14.77 | 14.57 | 116.89 | 35.59 | 74.14 | 137.82 | |
PB Ratio | -6.69 | -3.59 | 6.19 | 4.32 | -17.74 | -31.70 | |
P/TBV Ratio | - | - | 6.19 | 4.32 | - | - | |
EV/Sales Ratio | 23.31 | 14.89 | 92.74 | 21.58 | 99.57 | 167.24 | |
Debt / Equity Ratio | -0.04 | -0.11 | 0.09 | 0.05 | -3.53 | - | |
Asset Turnover | 0.10 | 0.10 | 0.03 | 0.08 | 0.08 | 0.04 | |
Quick Ratio | 0.63 | 0.42 | 2.59 | 3.81 | 0.82 | 0.53 | |
Current Ratio | 0.77 | 0.57 | 2.95 | 4.17 | 0.86 | 0.58 | |
Return on Equity (ROE) | - | -1405.34% | -314.40% | -932.50% | - | -487.65% | |
Return on Assets (ROA) | -342.96% | -246.44% | -139.63% | -130.48% | -217.18% | -150.27% | |
Return on Capital (ROIC) | - | -791.54% | -184.59% | -195.25% | -819.38% | -306.23% | |
Earnings Yield | -184.61% | -243.81% | -61.64% | -69.87% | -62.26% | -44.21% | |
FCF Yield | -157.69% | -208.29% | -59.64% | -79.07% | -62.45% | -42.72% | |
Buyback Yield / Dilution | -480.32% | -129.44% | -47.10% | -53.56% | -45.85% | -146.59% | |
Total Shareholder Return | -480.32% | -129.44% | -47.10% | -53.56% | -45.85% | -146.59% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.